The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Chernyshev I.V.

FGBU "NII urologii" Minzdravsotsrazvitiia Rossii, Moskva

Perepechin D.V.

Nauchno-issledovatel'skiĭ institut urologii, Moskva

The complex prophylaxis of thromboembolism in oncourologic patients

Authors:

Chernyshev I.V., Perepechin D.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2011;(9): 33‑38

Read: 1093 times


To cite this article:

Chernyshev IV, Perepechin DV. The complex prophylaxis of thromboembolism in oncourologic patients. Pirogov Russian Journal of Surgery. 2011;(9):33‑38. (In Russ.)

Recommended articles:
Hemo­rrhagic and thro­mboembolic complications in catheter abla­tion for atrial fibrillation. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(6):628-633

References:

  1. Flebologiya. Rukovodstvo dlya vrachei. Pod red. V.S. Savel'eva. M: Meditsina 2001.
  2. Andriyashkin V.V., Gologorskii V.A., Kirienko A.I. Profilaktika venoznykh tromboembolicheskikh oslozhnenii u gospital'nykh bol'nykh. RMZh 2001;9:3-14.
  3. Lyman G.H., Khorana A.A. Cancer, clots and consensus: new understanding of an old problem. J Clin Oncol 2009;27:29:4821-4826.
  4. Zangari M., Fink L.M., Elice F., Zhan F., Adcock D.M., Tricot G.J. Thrombotic events in patients with cancer receiving antiangiogenesis agents. J Clin Oncol 2009;27:29:4865-4873.
  5. Kuderer N.M., Ortel T.L., Francis C.W. Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol 2009;27:29:4902-4911.
  6. Francis C.W. Prevention of venous thromboembolism in hospitalized patients with cancer. J Clin Oncol 2009;27:29:4874-4880.
  7. Connolly G.C., Khorana A.A. Emerging risk stratification approaches to cancerassociated thrombosis: risk factors, biomarkers and a risk score. Thromb Res 2010;125:Suppl 2:1.
  8. Minimal'nye klinicheskie rekomendatsii Evropeiskogo obshchestva meditsinskoi onkologii (ESMO). Perevod - kollektiv avtorov. M 2008.
  9. Cosgrove R.H., Zacharski L.R., Racine E., Andersen J.C. Improved cancer mortality with low-molecular-weight heparin treatment: a review of the evidence. Semin Thromb Hemost 2002;28:1:79-87.
  10. Bergqvist et al. Tromboprophylactic effect of low molecular weight heparin starting in the evening before electivegeneral abdominal surgery. A comparison with low-dose heparin. Seminars in thrombosis and hemostasis - volume 16, supplement 1990.
  11. Leizorovicz A., Cohen A.T., Turpie A.G., Olsson C.G., Vaitkus P.T., Goldhaber S.Z. PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutelyill medical patients. Circulation 2004;110:7:874-879.
  12. Lee A. et al. Low-molecular-weight heparin versus a coumarin for the prevention of reccurent venous tromboembolism in patients with cancer. New Engl J Med 2003;349:2.
  13. Schmid P., Fischer A.G., Wuillemin W.A. Low-molecular-weight heparin in patients with renal insufficiency. Swiss Med Wkly 2009;139:31-32:438-452.
  14. Douketis J. et al. FRCPC for the Canadian critical care trials group. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin. An assessment of safety and pharmacodynamics: The DIRECT Study. Arch Intern Med 2008;168:16:1805-1812.
  15. Rabbat C.G., Cook D.J., Crowther M.A., McDonald E., Clarke F., Meade M.O., Lee K.A., Cook R.J. Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency. J Crit Care 2005;20:4:357-363.
  16. Savel'ev V.S., Pokrovskii A.V., Zatevakhin I.I., Kirienko A.I. Rossiiskie klinicheskie rekomendatsii po diagnostike i lecheniyu khronicheskikh zabolevanii ven, osnovannye na printsipakh dokazatel'noi meditsiny. Samara 2009.
  17. American Society of Clinical Oncology Guideline: recommendations for venous tromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007;25:34.
  18. Vardanyan A.V., Mumladze R.B., Melkonyan G.G. Prognozirovanie i profilaktika posleoperatsionnykh venoznykh tromboembolicheskikh oslozhnenii. Metodicheskaya razrabotka. M 2009.
  19. Bokarev I.N., Popova L.V., Kondrat'eva T.B. Venoznyi tromboembolizm: lechenie i profilaktika. Consilium Medicum (Khirurgiya) 2005;07:1.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.